Surgical Procedures Market (By Type: Gastrointestinal, Cardiovascular, Dental, Cosmetic, Urologic, Ophthalmic, Orthopedic, ENT, Nervous System, Obstetric/Gynecologic; By Channel: Physician Offices, Hospitals, ASCs) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2024-2033
The global surgical procedures market size was USD 3.17 trillion in 2023, accounted for USD 3.35 trillion in 2024, and is expected to reach around USD 5.52 trillion by 2033, expanding at a CAGR of 5.7% from 2024 to 2033.
Access our Healthcare Data Intelligence Tool with 10000+ Database, Visit: Towards Healthcare
The U.S. surgical procedures market size was estimated at USD 830 billion in 2023 and is predicted to be worth around USD 1,520 billion by 2033, at a CAGR of 6.3% from 2024 to 2033.
North America has held the largest revenue share of 37.14% in 2023. North America holds a major share in the surgical procedures market due to robust healthcare infrastructure, advanced medical technologies, and high healthcare spending. The region benefits from a well-established surgical ecosystem, including skilled healthcare professionals and cutting-edge surgical facilities. Additionally, a growing aging population and the prevalence of chronic diseases contribute to the demand for various surgical interventions. Favorable reimbursement policies and a strong focus on healthcare innovation further solidify North America's position as a leader in the global surgical procedures market.
Asia Pacific is estimated to witness the highest growth. Asia Pacific commands a significant share in the surgical procedures market due to factors such as a large patient population, rising healthcare investments, and increasing access to advanced medical technologies. The region experiences a surge in demand for surgical interventions driven by lifestyle changes, aging populations, and a growing incidence of chronic diseases. Additionally, improvements in healthcare infrastructure and a focus on medical tourism contribute to the expansion of the surgical procedures market in Asia Pacific, making it a key player in the global landscape.
Market Overview
Surgical procedures are diverse medical interventions involving incisions or tissue manipulation to diagnose, treat, or prevent health conditions. They fall into categories like elective (planned), emergency (urgent), and minimally invasive surgeries. Elective surgeries, such as joint replacements, enhance patients' quality of life through planned interventions. Emergency surgeries address critical conditions requiring immediate action.
Minimally invasive techniques, like laparoscopy, use smaller incisions and specialized tools, reducing recovery time and scarring. Skilled surgeons, often part of a healthcare team, conduct these procedures. Constant innovation in technology, materials, and techniques shapes the field, continually improving patient care globally. Surgical procedures play a pivotal role in advancing medical science, demonstrating the dynamic nature of healthcare practices.
Report Coverage | Details |
Growth Rate from 2024 to 2033 | CAGR of 5.7% |
Market Size in 2023 | USD 3.17 Trillion |
Market Size in 2024 | USD 3.35 Trillion |
Market Size by 2033 | USD 5.52 Trillion |
Largest Market | North America |
Base Year | 2023 |
Forecast Period | 2024 to 2033 |
Segments Covered | By Type and By Channel |
Regions Covered | North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa |
Global health infrastructure development and patient preferences
The expansion of global health infrastructure plays a vital role in boosting the demand for surgical procedures. As countries invest in upgrading healthcare facilities, the availability of advanced surgical services increases, driving a greater need for various surgical interventions. Improved medical infrastructure, equipped with modern technology, becomes a key factor in the growth of the surgical procedures market. Simultaneously, changing patient preferences has a significant impact on market demand.
With a better understanding of healthcare options, patients increasingly favor surgical solutions that align with their individual needs. This includes a preference for minimally invasive procedures, personalized treatment approaches, and thorough pre-and post-operative care. The emphasis on patient-centric care is reshaping the landscape, influencing a higher acceptance and demand for surgical procedures, and encouraging healthcare providers to adapt to these evolving preferences.
Limited access to healthcare and postoperative recovery time
Limited access to healthcare serves as a significant restraint on the demand for surgical procedures. In regions with inadequate healthcare infrastructure, individuals may face challenges in accessing necessary surgical interventions. This limitation stems from a lack of available medical facilities, skilled healthcare professionals, and resources, preventing a portion of the population from seeking or receiving surgical treatments. The resulting disparity in access hampers the overall growth potential of the surgical procedures market, creating barriers to healthcare equality.
Furthermore, the extended postoperative recovery time associated with certain surgical procedures acts as a deterrent for both patients and healthcare providers. Lengthy recovery periods can disrupt patients' daily lives and may lead individuals to opt for alternative, less invasive treatment options. The time commitment and potential impact on productivity and lifestyle choices contribute to hesitancy in choosing surgical interventions, influencing market demand. Addressing these challenges is crucial for ensuring broader accessibility to surgical procedures and improving overall market dynamics.
Advancements in robotic surgery and preventive surgery emphasis
Advancements in robotic surgery are pivotal in creating significant opportunities within the surgical procedures market. The continuous improvement and adoption of robotic-assisted surgical systems offer enhanced precision, reduced invasiveness, and shorter recovery times. This not only improves patient outcomes but also expands the range of surgeries that can be performed robotically. The evolving field of robotic surgery presents a niche for specialized procedures, attracting both patients and healthcare providers seeking advanced and efficient surgical solutions.
Simultaneously, the increasing emphasis on preventive surgeries represents a strategic opportunity for market growth. As healthcare systems shift towards proactive healthcare models, there is a growing focus on identifying and addressing health issues before they become more severe. This trend opens avenues for preventive surgeries, catering to high-risk populations or individuals with genetic predispositions. By promoting early intervention, this emphasis on prevention creates a unique space within the Surgical Procedures market, aligning with broader healthcare goals of improving long-term health outcomes and reducing the burden of chronic conditions.
In 2023, the cardiovascular segment held the highest market share of 24% on the basis of the type. In the surgical procedures market, the cardiovascular segment deals with surgeries related to the heart and blood vessels. This includes procedures like coronary artery bypass grafting and angioplasty. Current trends indicate a rising preference for less invasive methods, like transcatheter aortic valve replacement (TAVR), which shortens recovery periods and enhances patient results. The adoption of advanced technologies, such as robotic-assisted cardiac surgeries, underscores a noticeable shift towards innovative approaches in cardiovascular interventions within the overall realm of surgical procedures.
The orthopedic segment is anticipated to witness the highest growth at a significant CAGR of 6.2% during the projected period. In the surgical procedures market, the orthopedic segment deals with surgeries related to the musculoskeletal system, including joint replacements, fracture repairs, and spinal procedures. Current trends in orthopedic surgery emphasize the adoption of minimally invasive techniques like arthroscopy and robotic assistance, offering patients faster recovery and decreased post-operative discomfort. As the aging population contributes to a rise in orthopedic conditions, ongoing innovations in surgical methods and implant technologies are shaping the segment's growth, enhancing overall patient care and outcomes.
According to the channel, the hospitals segment has held 45% revenue share in 2023. The hospital segment in the surgical procedures market refers to the channel where surgical interventions are primarily conducted within healthcare facilities. Hospitals serve as critical hubs for various surgical procedures, ranging from routine surgeries to complex interventions.
A notable trend in this segment includes an increasing adoption of advanced technologies, such as robotic-assisted surgery, to enhance precision and minimize invasiveness. Additionally, there's a growing emphasis on streamlined processes, interdisciplinary collaboration, and patient-centric care within hospital settings to optimize surgical outcomes and patient satisfaction.
The physician offices segment is anticipated to witness the highest growth over the projected period. The physician offices segment in the surgical procedures market refers to medical practices where physicians perform various surgeries. This channel is witnessing a trend towards increased in-office surgical procedures due to advancements in minimally invasive techniques, allowing for quicker recovery and reduced hospitalization.
Physicians are embracing technologies that enable them to conduct certain surgeries in their offices, offering convenience for patients and potential cost savings. This trend aligns with a broader shift towards outpatient and ambulatory surgical care in the healthcare landscape.
Recent Developments
Segments Covered in the Report
By Type
By Channel
By Geography
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology (Premium Insights)
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Surgical Procedures Market
5.1. COVID-19 Landscape: Surgical Procedures Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Surgical Procedures Market, By Type
8.1. Surgical Procedures Market, by Type, 2024-2033
8.1.1. Gastrointestinal
8.1.1.1. Market Revenue and Forecast (2021-2033)
8.1.2. Cardiovascular
8.1.2.1. Market Revenue and Forecast (2021-2033)
8.1.3. Dental, Cosmetic
8.1.3.1. Market Revenue and Forecast (2021-2033)
8.1.4. Urologic
8.1.4.1. Market Revenue and Forecast (2021-2033)
8.1.5. Ophthalmic
8.1.5.1. Market Revenue and Forecast (2021-2033)
8.1.6. Orthopedic
8.1.6.1. Market Revenue and Forecast (2021-2033)
8.1.7. ENT
8.1.7.1. Market Revenue and Forecast (2021-2033)
8.1.8. Nervous System
8.1.8.1. Market Revenue and Forecast (2021-2033)
8.1.9. Obstetric/Gynecologic
8.1.9.1. Market Revenue and Forecast (2021-2033)
Chapter 9. Global Surgical Procedures Market, By Channel
9.1. Surgical Procedures Market, by Channel, 2024-2033
9.1.1. Physician Offices
9.1.1.1. Market Revenue and Forecast (2021-2033)
9.1.2. Hospitals
9.1.2.1. Market Revenue and Forecast (2021-2033)
9.1.3. ASCs
9.1.3.1. Market Revenue and Forecast (2021-2033)
Chapter 10. Global Surgical Procedures Market, Regional Estimates and Trend Forecast
10.1. North America
10.1.1. Market Revenue and Forecast, by Type (2021-2033)
10.1.2. Market Revenue and Forecast, by Channel (2021-2033)
10.1.3. U.S.
10.1.3.1. Market Revenue and Forecast, by Type (2021-2033)
10.1.3.2. Market Revenue and Forecast, by Channel (2021-2033)
10.1.4. Rest of North America
10.1.4.1. Market Revenue and Forecast, by Type (2021-2033)
10.1.4.2. Market Revenue and Forecast, by Channel (2021-2033)
10.2. Europe
10.2.1. Market Revenue and Forecast, by Type (2021-2033)
10.2.2. Market Revenue and Forecast, by Channel (2021-2033)
10.2.3. UK
10.2.3.1. Market Revenue and Forecast, by Type (2021-2033)
10.2.3.2. Market Revenue and Forecast, by Channel (2021-2033)
10.2.4. Germany
10.2.4.1. Market Revenue and Forecast, by Type (2021-2033)
10.2.4.2. Market Revenue and Forecast, by Channel (2021-2033)
10.2.5. France
10.2.5.1. Market Revenue and Forecast, by Type (2021-2033)
10.2.5.2. Market Revenue and Forecast, by Channel (2021-2033)
10.2.6. Rest of Europe
10.2.6.1. Market Revenue and Forecast, by Type (2021-2033)
10.2.6.2. Market Revenue and Forecast, by Channel (2021-2033)
10.3. APAC
10.3.1. Market Revenue and Forecast, by Type (2021-2033)
10.3.2. Market Revenue and Forecast, by Channel (2021-2033)
10.3.3. India
10.3.3.1. Market Revenue and Forecast, by Type (2021-2033)
10.3.3.2. Market Revenue and Forecast, by Channel (2021-2033)
10.3.4. China
10.3.4.1. Market Revenue and Forecast, by Type (2021-2033)
10.3.4.2. Market Revenue and Forecast, by Channel (2021-2033)
10.3.5. Japan
10.3.5.1. Market Revenue and Forecast, by Type (2021-2033)
10.3.5.2. Market Revenue and Forecast, by Channel (2021-2033)
10.3.6. Rest of APAC
10.3.6.1. Market Revenue and Forecast, by Type (2021-2033)
10.3.6.2. Market Revenue and Forecast, by Channel (2021-2033)
10.4. MEA
10.4.1. Market Revenue and Forecast, by Type (2021-2033)
10.4.2. Market Revenue and Forecast, by Channel (2021-2033)
10.4.3. GCC
10.4.3.1. Market Revenue and Forecast, by Type (2021-2033)
10.4.3.2. Market Revenue and Forecast, by Channel (2021-2033)
10.4.4. North Africa
10.4.4.1. Market Revenue and Forecast, by Type (2021-2033)
10.4.4.2. Market Revenue and Forecast, by Channel (2021-2033)
10.4.5. South Africa
10.4.5.1. Market Revenue and Forecast, by Type (2021-2033)
10.4.5.2. Market Revenue and Forecast, by Channel (2021-2033)
10.4.6. Rest of MEA
10.4.6.1. Market Revenue and Forecast, by Type (2021-2033)
10.4.6.2. Market Revenue and Forecast, by Channel (2021-2033)
10.5. Latin America
10.5.1. Market Revenue and Forecast, by Type (2021-2033)
10.5.2. Market Revenue and Forecast, by Channel (2021-2033)
10.5.3. Brazil
10.5.3.1. Market Revenue and Forecast, by Type (2021-2033)
10.5.3.2. Market Revenue and Forecast, by Channel (2021-2033)
10.5.4. Rest of LATAM
10.5.4.1. Market Revenue and Forecast, by Type (2021-2033)
10.5.4.2. Market Revenue and Forecast, by Channel (2021-2033)
Chapter 11. Company Profiles
11.1. Johnson & Johnson
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. Medtronic
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. Stryker Corporation
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. Becton, Dickinson and Company (BD)
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. Recent Initiatives
11.5. Olympus Corporation
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. Zimmer Biomet
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. Abbott Laboratories
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. Boston Scientific Corporation
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
11.9. Ethicon (a subsidiary of Johnson & Johnson)
11.9.1. Company Overview
11.9.2. Product Offerings
11.9.3. Financial Performance
11.9.4. Recent Initiatives
11.10. Intuitive Surgical
11.10.1. Company Overview
11.10.2. Product Offerings
11.10.3. Financial Performance
11.10.4. Recent Initiatives
Chapter 12. Research Methodology
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
Chapter 13. Appendix
13.1. About Us
13.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client